Unusual Presentation of a Sphenoidal Sinus Neuroendocrine Tumor: A Case Report and Review of Literature.

antineoplastic combined treatment protocol electron and proton beam therapy etoposide neuroendocrine carcinoma (nec) paranasal sinus neoplasm sphenoid sinus

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
04 Mar 2021
Historique:
entrez: 9 4 2021
pubmed: 10 4 2021
medline: 10 4 2021
Statut: epublish

Résumé

Neuroendocrine tumors (NETs) have a heterogeneous pathology and indolent behavior, with the most common location being the gastrointestinal tract and then the lungs. The head and neck are rare sites of NET presentation with varied clinical signs and symptoms, which occasionally delay the diagnosis, thereby leading to an advanced stage at presentation. We present a rare case of paranasal sinus small cell neuroendocrine tumor and perform a review of the literature. A 71-year-old man presented with continuous bleeding from the left nostril and nasal congestion without any prior medical history. Clinical examination revealed nasal congestion, rhinorrhea, postnasal drip, and active bleeding. The laboratory data were within normal limits. Imaging studies showed a left sphenoid sinus mass extending to the left ethmoid sinus with a break in the cribriform plate encephalocele. An enlarged lymph node measuring 2.2 cm was noted in the left neck and supraclavicular region. The evaluation through stereotactic endoscopic sinus surgery and biopsy revealed left nasopharyngeal, sphenoid sinus, and ethmoid sinus masses. Pathologic biopsy findings were consistent with high-grade, malignant, small, round blue cell tumors. Immunohistochemical analysis confirmed high-grade small cell neuroendocrine carcinoma. The patient was diagnosed with stage IV (TXN2bM0, T: tumor size, N: lymph node, M: metastasis) high-grade neuroendocrine tumor of the left paranasal sinus. He was treated with concurrent chemoradiation therapy with two cycles of etoposide and cisplatin and radiation therapy with proton beam radiation therapy followed by two cycles of adjuvant etoposide cisplatin chemotherapy. The patient showed a good response to the treatment, as confirmed using imaging. He is currently being regularly followed up with serial imaging.

Identifiants

pubmed: 33833913
doi: 10.7759/cureus.13689
pmc: PMC8019145
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e13689

Informations de copyright

Copyright © 2021, Kaur et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Cancer Treat Rev. 2009 May;35(3):228-36
pubmed: 19068273
Int J Radiat Oncol Biol Phys. 2009 Jun 1;74(2):477-81
pubmed: 19004574
J Clin Oncol. 2008 Jun 20;26(18):3063-72
pubmed: 18565894
Indian J Pathol Microbiol. 2010 Jan-Mar;53(1):28-34
pubmed: 20090218
Oral Oncol. 2017 Jun;69:92-98
pubmed: 28559027
Head Neck. 2012 Oct;34(10):1372-6
pubmed: 22052583
Oncologist. 2019 Dec;24(12):1562-1569
pubmed: 31391295
Ther Adv Endocrinol Metab. 2018 Oct 31;10:2042018818804698
pubmed: 30800264
Cureus. 2019 Mar 26;11(3):e4322
pubmed: 31183301
Int J Clin Exp Pathol. 2014 Apr 15;7(5):2678-82
pubmed: 24966986
Int Arch Otorhinolaryngol. 2014 Oct;18(Suppl 2):S149-56
pubmed: 25992139
Arch Pathol Lab Med. 2010 Nov;134(11):1628-38
pubmed: 21043816
Head Neck Pathol. 2016 Mar;10(1):85-94
pubmed: 26830400
Int Forum Allergy Rhinol. 2015 May;5(5):448-53
pubmed: 25727332
Cancer. 2002 May 15;94(10):2623-34
pubmed: 12173330
J Pak Med Assoc. 2018 Jan;68(1):133-136
pubmed: 29371736
Korean J Radiol. 2019 Jan;20(1):5-17
pubmed: 30627018
Oral Oncol. 2016 Dec;63:1-9
pubmed: 27938993
Ann Transl Med. 2018 Jun;6(12):252
pubmed: 30069454

Auteurs

Jasmeet Kaur (J)

Internal Medicine, Saint Joseph Mercy Oakland Hospital, Pontiac, USA.

Swathi Mogulla (S)

Internal Medicine, Saint Joseph Mercy Oakland Hospital, Pontiac, USA.

Ambreen Malik (A)

Internal Medicine, Saint Joseph Mercy Oakland Hospital, Pontiac, USA.

Sandeep Garg (S)

Hematology and Medical Oncology, Saint Joseph Mercy Oakland Hospital, Pontiac, USA.

Classifications MeSH